Objective: To compare the efficacy of simultaneous and sequential administration of oxytocin and intrauterine balloons in labor induction.

Methods: The databases of Cochrane Library, Web of Science, PubMed, ClinicalTrials.gov, and Embase were thoroughly searched from their inception to November 2023. Randomized controlled trials (RCTs) investigating the simultaneous and sequential use of oxytocin and intrauterine balloons for labor induction in pregnancy were included. The meta-analysis was performed using RevMan 5.3 statistical software. Heterogeneity among the selected studies was evaluated using the statistic. Dichotomous outcomes were estimated using relative risk (RR) with corresponding 95% confidence intervals (CI), while continuous outcomes were measured as the mean difference (MD).

Results: A total of eight studies, involving a total of 1,315 nulliparous and multiparous women with an unfavorable cervix, were included in the systematic review. Moreover, a subgroup analysis was conducted, separately evaluating nulliparous and multiparous women. Compared with the sequential groups, simultaneous use of oxytocin and intrauterine balloons resulted in a significantly higher rate of delivery within 24h in nulliparas (RR = 1.30, 95%CI:1.04, 1.63,  = 0.02), a higher rate of vaginal delivery within 24h in multiparas (RR = 1.32, 95%CI:1.15,1.51,  < 0.00001), a superior rate of delivery within 12h and a shorter time to delivery in both nulliparas and multiparas. No statistically significant differences were observed in cesarean delivery and maternal and neonatal adverse outcomes between the sequential and simultaneous groups.

Conclusions: These findings provide support for the simultaneous use of intrauterine balloons and oxytocin during labor induction in nulliparous women. Additionally, this approach may also prove beneficial for multiparas.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14767058.2024.2395490DOI Listing

Publication Analysis

Top Keywords

oxytocin intrauterine
16
simultaneous sequential
12
intrauterine balloons
12
labor induction
8
sequential administration
8
administration oxytocin
8
systematic review
8
balloons labor
8
nulliparous multiparous
8
multiparous women
8

Similar Publications

Evidence-based cesarean delivery: postoperative care (part 10).

Am J Obstet Gynecol MFM

November 2024

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, PA (Bender and Berghella). Electronic address:

The following review focuses on routine postoperative care after cesarean delivery (CD), including specific Enhanced Recovery After Cesarean recommendations as well as important postpartum counseling points. Following CD, there is insufficient evidence to support administration of prophylactic multi-dose antibiotics to all patients. Additional antibiotic doses are indicated for the following scenarios: patients with obesity who did not receive preoperative azithromycin, CD lasting ≥4 hours since prophylactic dose, blood loss >1500 mL, or those with an intra-amniotic infection.

View Article and Find Full Text PDF
Article Synopsis
  • Mothers in Africa face a significantly higher risk of dying from complications after cesarean deliveries compared to high-income countries, primarily due to postpartum hemorrhage (PPH).
  • A survey conducted among anesthesiologists and obstetricians in 140 hospitals across Africa aimed to assess the readiness of these facilities to implement World Health Organization (WHO) guidelines for preventing and treating PPH.
  • The survey found that while many hospitals had access to key medications like oxytocin and crystalloids, there were gaps in the availability of some critical treatments, such as heat-stable carbetocin and intrauterine balloon tamponades, highlighting the need for improved resources and training in PPH management.
View Article and Find Full Text PDF

Background: The prostaglandin E1 analog "misoprostol" is a drug that has powerful ecbolic effects and can be beneficial in the prevention and treatment of postpartum hemorrhage, which is the leading cause of maternal mortality worldwide.

Objectives: To assess the value of adding intrauterine misoprostol together with intravenous oxytocin injection compared with sublingual misoprostol together with intravenous oxytocin injection during elective cesarean section to reduce blood loss intraoperatively and prevent postpartum hemorrhage.

Methods: A total of 192 pregnant women were counseled and recruited from the labor and delivery unit at Kasr Al Aini Hospital, Cairo University, and equally randomized into two groups.

View Article and Find Full Text PDF

Objective: To compare the efficacy of simultaneous and sequential administration of oxytocin and intrauterine balloons in labor induction.

Methods: The databases of Cochrane Library, Web of Science, PubMed, ClinicalTrials.gov, and Embase were thoroughly searched from their inception to November 2023.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of high-dose versus low-dose oxytocin for enhancing labor in women experiencing delayed progress.
  • A meta-analysis of 21 studies, including 18 randomized controlled trials with over 14,000 patients, found no significant differences in key outcomes like cesarean rates or neonatal mortality between the doses.
  • High-dose oxytocin was linked to a significantly higher incidence of uterine tachysystole, indicating that a low-dose regimen may be safer and equally effective for labor augmentation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!